Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of platinum-based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer
MOH_2020-03-09_008757Phase 3Recruiting
- Sponsor
- GEICAM
- Start
- Jan 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atezolizumab and niraparib, sponsored by GEICAM. Started Jan 2020; status: recruiting.
02
Drugs
atezolizumabniraparib
Beyond the preview
Go deeper on MOH_2020-03-09_008757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-03-09_008757.